Pseudopheochromocytoma is a condition in which a person experiences dramatic, episodic surges in blood pressure that closely mimic the symptoms of a pheochromocytoma, the rare adrenal tumor, but without any tumor present and without the sustained hormone elevations that would explain it.1PubMed Central. Pseudopheochromocytoma Because the episodes look so alarming, patients often cycle through emergency departments, endocrinologists, and imaging suites before anyone considers that the real driver is an overreactive sympathetic nervous system intertwined with psychological factors. The condition is under-recognized, frequently misdiagnosed, and more treatable than most patients or their doctors expect.
What the Episodes Feel Like
During a paroxysm, blood pressure can spike into dangerously high territory within minutes. Patients typically report a sudden pounding heartbeat, flushing, headache, chest tightness, sweating, and a sense of impending doom. The overlap with panic attacks is obvious, and many patients are initially told they are simply anxious, which is both partly true and deeply insufficient. The episodes can last anywhere from a few minutes to several hours, and the blood pressure readings recorded during them are often high enough that emergency physicians reflexively order the full pheochromocytoma workup.
The similarity to a true catecholamine-secreting tumor is the whole reason the condition gets its name. “Pseudo” means false; the clinical picture mimics pheochromocytoma, but the underlying cause is fundamentally different. The symptoms are driven by sympathetic nervous system activation rather than a tumor pumping out adrenaline and related hormones.2PubMed. Severe paroxysmal hypertension (pseudopheochromocytoma)
Why It Is Not Pheochromocytoma
Pheochromocytoma is an actual tumor, usually in one of the adrenal glands, that produces excess catecholamines. Those hormones flood the bloodstream and cause sustained or episodic hypertension, rapid heart rate, and other symptoms. The hallmark of pheochromocytoma on lab work is markedly elevated plasma or urine catecholamines and their breakdown products, especially metanephrines.
In pseudopheochromocytoma, those lab values come back normal or only modestly elevated, and imaging reveals no adrenal mass. One study directly comparing patients with pseudopheochromocytoma to healthy controls found that norepinephrine levels were normal, but baseline epinephrine was roughly twice as high and baseline metanephrine about 80 percent higher than in controls.3Journal of Hypertension. Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma Those elevations are real, but they fall well short of what you would see with a catecholamine-secreting tumor, where metanephrine levels are often several times above the upper limit of normal. The same study found that when pseudopheochromocytoma patients were given glucagon, a drug that provokes catecholamine release, their epinephrine response was about six times larger than in controls, suggesting the adrenal glands are hyper-responsive to stimulation rather than autonomously overproducing hormones.
Imaging plays a confirmatory role. CT or MRI of the abdomen shows normal adrenal glands. In ambiguous cases, specialized nuclear medicine scans can also be used. One detailed case report documented a patient whose CT was normal and whose copper-labeled octreotate PET scan found no evidence of any adrenal or extra-adrenal mass, effectively ruling out both pheochromocytoma and its cousin, paraganglioma.4JCEM Case Reports. Pseudopheochromocytoma With Catecholamine Excess and End-organ Damage: A 30-year Course Treated With Escitalopram
What Drives the Blood Pressure Surges
The core problem appears to be an amplified cardiovascular response to normal or mildly elevated levels of catecholamines, paired with heightened sympathetic nervous system activity.5PubMed. Catecholamine excess: pseudopheochromocytoma and beyond Think of it this way: the body is producing the same hormones everyone else has, but the blood vessels and heart react to them as though a much larger dose were present. The exact mechanism is still not fully understood, and the picture is complicated by the fact that different catecholamines can be preferentially elevated in different patients. Someone with relatively more epinephrine elevation may present with a fast heart rate and flushing, while someone with more norepinephrine-driven tone may have higher diastolic pressures and less of the flushing.
One useful physiological test that highlights this hyperreactivity involves the Valsalva maneuver, the forced exhalation against a closed airway that you might do when straining or popping your ears. In healthy people and in those with garden-variety high blood pressure, blood pressure overshoots modestly after the maneuver ends. In pheochromocytoma patients, that overshoot is actually blunted because their adrenergic receptors are desensitized from chronic catecholamine flooding. But in pseudopheochromocytoma patients, the overshoot is dramatically exaggerated. One study measured a systolic overshoot of about 78 mmHg in pseudopheochromocytoma patients, compared to roughly 31 mmHg in patients with ordinary hypertension and just 8 mmHg in those with a true pheochromocytoma.6Hypertension. Blood pressure response to the Valsalva maneuver in pheochromocytoma and pseudopheochromocytoma That finding reinforces the idea that the adrenergic system in pseudopheochromocytoma is hyperactive, not flooded from an external source. The exaggerated response was suppressed when patients received both alpha- and beta-adrenergic blockers, suggesting both branches of the adrenergic signaling pathway contribute.
The Psychological Thread
This is where pseudopheochromocytoma diverges most sharply from the typical endocrine or cardiology diagnosis. A significant proportion of patients have a history of psychological trauma, repressed emotions, or a coping style that involves suppressing distressing feelings rather than processing them.7PubMed Central. Pseudopheochromocytoma This does not mean the condition is “all in your head.” The blood pressure spikes are very real, measurable, and can cause genuine organ damage over time. But the trigger for the sympathetic nervous system activation often has a psychological origin.
Many patients resist this explanation, and understandably so. They arrive in an emergency department with a systolic blood pressure over 200 mmHg and are told that the root cause may involve unresolved trauma or emotional suppression. The framing can feel dismissive unless the clinician takes the time to explain that the nervous system’s fight-or-flight response is a physical mechanism, not a character flaw, and that emotions can drive it as powerfully as any tumor. The fact that highly effective treatments exist, and that most of them target the brain’s regulation of the sympathetic system, tends to make the explanation more credible to skeptical patients over time.
Getting to the Diagnosis
The diagnostic journey for pseudopheochromocytoma is often long and frustrating. Because the episodes are intermittent and because blood pressure between episodes can be completely normal, patients may visit the emergency department repeatedly during paroxysms yet have unremarkable readings at scheduled clinic appointments. Standard hypertension workups focus on kidney function, aldosterone, thyroid hormones, and catecholamines. The first three come back normal. The catecholamine results come back normal or borderline elevated, which is confusing because the patient clearly had wildly elevated blood pressure during the last episode.
The key diagnostic step is demonstrating that catecholamines and metanephrines are not elevated enough to suggest a tumor, while simultaneously confirming that the blood pressure surges are real and not fabricated. Ambulatory blood pressure monitoring, which tracks readings throughout the day and night via a portable cuff, can capture the paroxysms objectively. Timed urine collections and plasma metanephrine draws, ideally done during or soon after an episode, help establish the biochemical baseline.
Once imaging has ruled out an adrenal or extra-adrenal mass and lab work has excluded other secondary causes of hypertension, such as renal artery stenosis, hyperaldosteronism, or thyroid disease, the diagnosis of pseudopheochromocytoma is made by exclusion. There is no single definitive biomarker. It is fundamentally a diagnosis arrived at after everything else has been crossed off the list.8PubMed Central. Pseudopheochromocytoma That process can take months or even years, and many patients accumulate multiple emergency visits and subspecialty referrals before the picture comes together.
How It Is Treated
Treatment is where the story gets encouraging. Because the underlying mechanism involves the sympathetic nervous system and often has psychological underpinnings, the most effective approach combines medications that quiet sympathetic overdrive with psychological therapy.
Antidepressants, particularly selective serotonin reuptake inhibitors, have emerged as a surprisingly effective treatment for the paroxysms themselves. A study of 25 patients with pseudopheochromocytoma treated with an antidepressant found a 92 percent response rate. Of those responders, 84 percent experienced complete cessation of their blood pressure paroxysms and another 8 percent saw a substantial reduction in episode frequency.9medRxiv. High Response Rate to Antidepressants in the Management of Paroxysmal Hypertension (Pseudopheochromocytoma) For a condition that had previously sent these same patients to emergency departments repeatedly, that response rate is striking.
Earlier work found that some patients required a combination of alpha- and beta-adrenergic blockers alongside their antidepressant to achieve control, and a subset also benefited from an anxiolytic medication.10JAMA Internal Medicine. Severe Paroxysmal Hypertension (Pseudopheochromocytoma): Understanding the Cause and Treatment The alpha- and beta-blockers make physiological sense: if the blood vessels and heart are overreacting to catecholamines, blocking the receptors those hormones bind to should dampen the surges. But blockers alone without an antidepressant typically do not resolve the problem completely, which is consistent with the idea that the upstream driver is central, in the brain’s regulation of the sympathetic outflow.
The best results seem to come from collaboration between a hypertension specialist, who manages the blood pressure medications, and a psychiatrist or psychologist with expertise in cognitive-behavioral approaches to panic and stress management.11PubMed Central. Pseudopheochromocytoma Psychotherapy can address the repressed emotions or trauma history that may feed the sympathetic overdrive. One published case described a patient who had suffered hypertensive paroxysms for 30 years before finally being started on escitalopram. Within seven months she reported only two mild episodes, felt better than she had in decades, and over the next 18 months had no further hospital admissions for hypertensive crises.12JCEM Case Reports. Pseudopheochromocytoma With Catecholamine Excess and End-organ Damage: A 30-year Course Treated With Escitalopram Thirty years of emergency visits resolved by one well-chosen medication.
When Medications or Substances Are the Trigger
Not every case of pseudopheochromocytoma traces back to psychological factors. Certain medications and substances can provoke the same clinical picture through direct pharmacological effects on the sympathetic nervous system. Stimulant drugs, decongestants containing sympathomimetic agents, and certain dietary supplements can all precipitate paroxysmal hypertension that looks identical to the syndrome.
One well-documented and underappreciated trigger is the abrupt withdrawal of anxiolytic or sedative medications, particularly benzodiazepines. A case report described life-threatening paroxysmal hypertension with secondary brain damage following the sudden discontinuation of an anxiolytic regimen. The authors concluded that abrupt withdrawal generated sympathetic overdrive severe enough to mimic a pheochromocytoma crisis and emphasized that a psychopharmacological approach to treatment was essential once other secondary causes had been excluded.13PubMed Central. Pseudopheochromocytoma induced by anxiolytic withdrawal The broader lesson is that any medication whose sudden removal unleashes sympathetic rebound can produce this presentation. Clinicians evaluating paroxysmal hypertension should always take a thorough medication and substance history, including recently discontinued drugs.
Monoamine oxidase inhibitors present a related but distinct risk: when combined with tyramine-rich foods or certain other drugs, they can produce a hypertensive crisis that superficially resembles pseudopheochromocytoma. The distinction matters because the treatment differs. A tyramine reaction is pharmacological and self-limited once the offending agent is removed, while true pseudopheochromocytoma tends to recur unless the underlying sympathetic hyperreactivity is addressed.
Cardiovascular Risks of Repeated Paroxysms
It would be a mistake to treat pseudopheochromocytoma as benign just because no tumor is present. Repeated episodes of extreme blood pressure elevation stress the heart and blood vessels in real, cumulative ways. Acute complications can include hypertensive encephalopathy, where the brain swells from excessive blood pressure, and stress-induced cardiomyopathy, sometimes called takotsubo syndrome, where the heart’s pumping chamber temporarily balloons out and weakens. The 30-year case described earlier is a cautionary example: by the time the patient finally received effective treatment, she had already sustained end-organ damage from decades of uncontrolled paroxysms.14JCEM Case Reports. Pseudopheochromocytoma With Catecholamine Excess and End-organ Damage: A 30-year Course Treated With Escitalopram
The risk of organ damage is one reason the condition deserves faster recognition. If a patient is having blood pressure readings above 200 mmHg every few weeks and the workup for pheochromocytoma keeps coming back negative, that is not a reason to stop investigating. It is a reason to shift the investigation toward pseudopheochromocytoma and begin treatment while the search for secondary causes continues.
Why It Is So Often Missed
Several features of pseudopheochromocytoma conspire to keep it under the radar. First, it is rare enough that many physicians have never encountered a case, let alone diagnosed one. Second, its episodic nature means that patients often present for evaluation between paroxysms, when their blood pressure and lab work look unremarkable. Third, the psychological component creates a diagnostic awkwardness: physicians are understandably reluctant to tell a patient with genuinely alarming blood pressure that the cause is linked to emotions, and patients are understandably reluctant to accept that framing.
There is also a structural problem in how medicine is organized. The condition sits at the intersection of endocrinology, cardiology, and psychiatry, and no single specialty fully owns it. An endocrinologist may rule out pheochromocytoma and consider the case closed. A cardiologist may prescribe standard blood pressure medications that fail to prevent the paroxysms. A psychiatrist may not be asked to evaluate a patient whose chief complaint is high blood pressure. The most effective management model, a deliberate collaboration between a hypertension specialist and a mental health professional, requires someone to recognize what the diagnosis is and assemble that team. Without that recognition, patients bounce between specialties indefinitely.
How It Differs from Panic Disorder
Panic disorder is probably the most common misdiagnosis applied to pseudopheochromocytoma patients, and the overlap is genuine. Both conditions involve sudden sympathetic activation, both produce racing heartbeat and a feeling of dread, and both can send people to emergency departments. But pseudopheochromocytoma produces objectively higher blood pressure readings than typical panic attacks. Systolic pressures above 200 mmHg are common during paroxysms, whereas panic attacks more typically cause modest elevations.
The distinction also matters for treatment planning. While SSRIs help in both conditions, patients with pseudopheochromocytoma often need adjunctive alpha- and beta-blockers to control the hemodynamic surges, something that is rarely necessary in standard panic disorder. And patients with pseudopheochromocytoma tend to show the amplified cardiovascular responsiveness to catecholamines described earlier, something that can be demonstrated physiologically and that is not a feature of uncomplicated panic disorder. In short, the conditions share a sympathetic nervous system axis but differ in the degree to which the cardiovascular system is affected.
Practical Advice for Patients Stuck in the Diagnostic Loop
If you or someone you know has been experiencing repeated episodes of severe high blood pressure with negative pheochromocytoma workups, a few practical steps can move the process forward. Keep a log of episodes: when they happen, what you were doing or feeling beforehand, how high your blood pressure goes if you have a home monitor, and how long they last. That log gives clinicians something objective to work with during a between-episode visit.
Ask your doctor about 24-hour ambulatory blood pressure monitoring, which can sometimes capture a paroxysm and document the pattern. If your catecholamine and metanephrine levels have been tested multiple times and come back normal or only mildly elevated, ask whether pseudopheochromocytoma has been considered. Be open to the possibility that a mental health evaluation is not dismissive but diagnostic. The 92 percent response rate to antidepressants in one series is the kind of number that should make both patients and physicians willing to pursue this path seriously.
Finally, if you are prescribed an anxiolytic or sedative medication and are considering stopping it, do so only under medical supervision with a gradual taper. Abrupt withdrawal can provoke exactly the kind of sympathetic storm that underlies pseudopheochromocytoma, and the consequences can be severe.15PubMed Central. Pseudopheochromocytoma induced by anxiolytic withdrawal